摘要
目的:探讨TRAIL联合阿霉素和IFN-γ对人骨肉瘤细胞凋亡的作用及可能机制。方法:采用MTT法检测不同浓度及不同时间下TRAIL的抗癌活性。用流式细胞仪检测TRAIL、阿霉素和IFN-γ单独及联合应用后人骨肉瘤MG-63的凋亡率。RT-PCR法检测DR5及Yin Yang1(YY1)mRNA在加药前后的表达。结果:TRAIL、阿霉素、IFN-γ三者联合作用于MG-63细胞后,能显著增强对MG-63的杀伤、抑制增殖及诱导凋亡作用,明显高于单独应用TRAIL组或阿霉素组(P<0.05)。结论:TRAIL、阿霉素、IFN-γ三者联用能显著提高骨肉瘤细胞MG-63生长抑制和诱导凋亡作用,其机制可能与DR5mRNA表达上调及Yin Yang1(YY1)mRNA表达被抑制有关。
Objective: To investigate the effect and potential mechanism of combined TRAIL,adriamycin(ADM) and IFN-γ on apoptosis of human osteosarcoma cells in vitro.Methods:Osteosarcoma cells were cultured with TRAIL at different concentrations and different time periods.Methyl thiazolyl tetrazolium(MTT) assay was used to measure the anti-cancer activity of TRAIL.Flow cytometry was used to detect the apoptosis induced by TRAIL,ADM alone and TRAIL,ADM and IFN-γ combined.Expression of DR5 and Yin Yang1(YY1) mRNA was examined by RT-PCR.Results:The combination of the three treatments induced significantly higher apoptosis and cytotoxicity than exposure to TRAIL,ADM or IFN-γ alone,but the combination of two of the three agents did not show synergistic effect.Conclusion:There might be a synergistical interaction between paclitaxel in terms of cytotoxicity and its mechanisms might be involved in the up-regulation of DR5 gene and the down-regulation of YY1.
出处
《中国中医骨伤科杂志》
CAS
2012年第10期5-8,共4页
Chinese Journal of Traditional Medical Traumatology & Orthopedics
基金
国家自然科学基金资助项目(30700841)